TABLE 5.
Comparisons of risks of metabolic syndrome 3 y later by baseline adipocyte fatty acid–binding protein (A-FABP) and adiponectin interactions1
| High adiponectin + low A-FABP | Low adiponectin + low A-FABP | High adiponectin + low A-FABP | Low adiponectin + high A-FABP | P value | |
| Height (cm) | 150.5 ± 8.1 | 149.5 ± 6.9 | 151.4 ± 7.6 | 155.5 ± 6.8 | <0.01 |
| Weight (kg) | 42.1 ± 8.1 | 41.9 ± 9.0 | 48.9 ± 9.0 | 56.7 ± 9.7 | <0.01 |
| BMI (kg/m2) | 18.5 ± 2.5 | 18.6 ± 3.2 | 21.2 ± 2.9 | 23.4 ± 3.3 | <0.01 |
| WC (cm) | 62.7 ± 7.5 | 63.1 ± 8.0 | 69.8 ± 8.6 | 75.6 ± 9.5 | <0.01 |
| SBP (mm Hg) | 109.7 ± 10.2 | 108.9 ± 10.5 | 115.2 ± 12.1 | 115.3 ± 10.1 | <0.01 |
| DBP (mm Hg) | 70.2 ± 8.4 | 68.1 ± 7.5 | 71.6 ± 9.6 | 70.8 ± 8.8 | 0.14 |
| FBS (mmol/L) | 4.80 ± 0.52 | 4.66 ± 0.54 | 4.50 ± 0.41 | 4.53 ± 0.54 | 0.05 |
| TC (mmol/L) | 4.25 ± 0.78 | 4.02 ± 0.54 | 4.60 ± 0.96 | 4.55 ± 0.87 | 0.02 |
| TG (mmol/L) | 0.93 ± 0.51 | 0.89 ± 0.45 | 0.98 ± 0.55 | 1.27 ± 0.64 | <0.01 |
| HDL-C (mmol/L) | 1.30 ± 0.30 | 1.24 ± 0.26 | 1.29 ± 0.30 | 1.18 ± 0.31 | 0.24 |
| Insulin (μIU/mL) | 11.8 ± 7.4 | 11.4 ± 9.5 | 11.0 ± 6.7 | 16.9 ± 15.4 | 0.04 |
| HOMA-IR | 2.49 ± 1.63 | 2.39 ± 2.03 | 2.20 ± 1.38 | 3.44 ± 3.32 | 0.08 |
1
All values are means ± SDs. WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBS, fasting blood sugar; TC, total cholesterol; TG, triglyceride; HDL-C, HDL cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance. The interaction models were not significant. The groups were compared by ANOVA.